These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23077741)

  • 1. [Glucagon-like peptide 1 analogues in the treatment of type 2 diabetes mellitus].
    Christensen M; Vilsbøll T; Knop FK
    Ugeskr Laeger; 2012 Aug; 174(34):1935; discussion 1935. PubMed ID: 23077741
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glucagon-like peptide 1 analogues in the treatment of type 2 diabetes mellitus].
    Beck-Nielsen H
    Ugeskr Laeger; 2012 Jun; 174(23):1606-8. PubMed ID: 22673382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novo Nordisk replies to BMJ investigation on incretins and pancreatic damage.
    Moses A
    BMJ; 2013 Jul; 347():f4386. PubMed ID: 23842435
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucagon-like peptide-1 agonists in the treatment of type 2 diabetes.
    Edwards CM
    Br J Hosp Med (Lond); 2013 Apr; 74(4):198-201. PubMed ID: 23571389
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination therapy with liraglutide and sulfonylurea for a type 2 diabetic patient with high titer of anti-insulin antibodies produced by insulin therapy.
    Yoshida M; Asai M; Miyata M; Ogawa K; Maeda H; Oiso Y
    Diabetes Res Clin Pract; 2012 Jun; 96(3):e55-6. PubMed ID: 22257418
    [No Abstract]   [Full Text] [Related]  

  • 6. Q: Do incretin drugs for type 2 diabetes increase the risk of acute pancreatitis?
    Olansky L
    Cleve Clin J Med; 2010 Aug; 77(8):503-5. PubMed ID: 20682512
    [No Abstract]   [Full Text] [Related]  

  • 7. Incretin therapy and its effect on body weight in patients with diabetes.
    Lind M
    Prim Care Diabetes; 2012 Oct; 6(3):187-91. PubMed ID: 22613745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety of incretin based drugs.
    Montori VM
    BMJ; 2014 Apr; 348():g2779. PubMed ID: 24764568
    [No Abstract]   [Full Text] [Related]  

  • 9. [Incretin modulators, a new perspective in diabetes mellitus treatment].
    Lupaşcu FG; Geangalău IM; Pânzariu A; Profire L
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):630-4. PubMed ID: 23077965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current challenges in type 2 diabetes.
    Garber AJ
    Diabetes Obes Metab; 2012 Apr; 14 Suppl 2():1-3. PubMed ID: 22405263
    [No Abstract]   [Full Text] [Related]  

  • 11. [Liraglutide in the treatment of diabetes type 2].
    Novak B; Metelko Z
    Lijec Vjesn; 2011; 133(7-8):269-76. PubMed ID: 22165195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical challenges of managing type 2 diabetes and the potential of GLP-1-based therapies.
    Zinman B
    Diabetes Obes Metab; 2009 Dec; 11 Suppl 3():1-3. PubMed ID: 19878255
    [No Abstract]   [Full Text] [Related]  

  • 13. [DPP-IV inhibitors and GLP-1 analogues].
    Zettl H; Steinhilber D
    Pharm Unserer Zeit; 2010 Mar; 39(2):108-13. PubMed ID: 20196037
    [No Abstract]   [Full Text] [Related]  

  • 14. Albiglutide for the treatment of type 2 diabetes mellitus.
    McCarty DJ
    Nurse Pract; 2017 Feb; 42(2):10-11. PubMed ID: 28085780
    [No Abstract]   [Full Text] [Related]  

  • 15. Addition of incretin therapy to metformin in type 2 diabetes.
    Scheen AJ; Radermecker RP
    Lancet; 2010 Apr; 375(9724):1410-2. PubMed ID: 20417840
    [No Abstract]   [Full Text] [Related]  

  • 16. Choosing among the incretin agents and why it matters.
    Unger J
    J Fam Pract; 2010 May; 59(5 Suppl):S30-5. PubMed ID: 20544056
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin treatment for type 2 diabetes: when to start, which to use.
    Hamaty M
    Cleve Clin J Med; 2011 May; 78(5):332-42. PubMed ID: 21536829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New treatments for type 2 diabetes in the UK - an evolving landscape.
    Barnett AH
    Prim Care Diabetes; 2011 Apr; 5(1):1-7. PubMed ID: 20934929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incretins and amylin in pediatric diabetes: new tools for management of diabetes in youth.
    Wood JR; Silverstein J
    Curr Opin Pediatr; 2013 Aug; 25(4):502-8. PubMed ID: 23782574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antidiabetics and the incretin system].
    Høibraaten E; Folkersen J
    Tidsskr Nor Laegeforen; 2008 Sep; 128(17):1985. PubMed ID: 18787580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.